Another small study examined the effect of intralesional beta-interferon (IFN-β) injections (3–5 million units per injection administered three times weekly) combined with radiotherapy (40–50 Gy at 1.8 Gy fraction) in 20 patients with metastatic inoperable malignant melanoma. The gene discussed is IFNB1; the disease is melanoma.